HomeISCO • OTCMKTS
International Stem Cell Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.45M | 4.98% |
Operating expense | 1.35M | 6.62% |
Net income | 129.00K | 8.40% |
Net profit margin | 5.27 | 3.13% |
Earnings per share | — | — |
EBITDA | 221.00K | 11.06% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 920.00K | -28.68% |
Total assets | 5.55M | -0.84% |
Total liabilities | 5.14M | -3.15% |
Total equity | 404.00K | — |
Shares outstanding | 8.00M | — |
Price to book | -0.31 | — |
Return on assets | 7.47% | — |
Return on capital | 9.76% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 129.00K | 8.40% |
Cash from operations | -300.00K | -1,404.35% |
Cash from investing | -32.00K | 73.11% |
Cash from financing | -200.00K | — |
Net change in cash | -532.00K | -454.17% |
Free cash flow | -448.38K | -149.44% |
Previous close
$0.15
Day range
$0.18 - $0.18
Year range
$0.052 - $0.27
Market cap
1.45M USD
Avg Volume
5.91K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2001
Website
Employees
32
